Domov › Visok krvni tlak › Arizona
Klinične študije za Visok krvni tlak v Arizona
12 študij za Visok krvni tlak išče udeležence na lokacijah v Arizona.
Mesta v Arizona
Uradno besedilo študije (angleško)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Tucson
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07142356A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Banner - University Medical Center Tucson, Tucson
Vključevanje udeležencev
Starost 18–85 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07214376A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Arizona Clinical Trials - Chandler, Chandler
- Elite Clinical Studies, Phoenix
- Clinical Research Institute of Arizona, LLC, Sun City West
- in še 3
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Care Access - 801 South Power Road, Mesa, Mesa
- Absolute Clinical Research, Phoenix
- Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Surprise
- Research Site, Tucson
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- HonorHealth, Scottsdale
Vključevanje udeležencev
Starost 22–75 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Chandler
- Clinical Trial Site, Gilbert
- Clinical Trial Site, Mesa
- in še 8
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07181109Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
- Banner University Medical Center South, Tucson
- UAHS Center for Sleep, Circadian, & Neuroscience Research Department of Medicine, University of Arizona, Tucson
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07799961Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Phoenix
- Vanda Investigative Site, Tempe
- Vanda Investigative Site, Tucson
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT07090161bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
- University of Arizona, Tucson
Vključevanje udeležencev
Starost 60 in več · Vsi spoli · Posodobljeno 15. okt. 2025 · NCT06307574CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona
- School of Informatics Computing and Cyber Systems, Flagstaff
- Northern Arizona University, Flagstaff
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 5. jun. 2025 · NCT06487637Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.